Share Buy-back programme at SP Group A/S

February 7, 2025

On 26 August 2024 SP Group initiated a share buy-back programme, cf. company announcement no. 12/2024 of 23 August 2024.

According to the programme, SP Group will in the period from 26 August 2024 until 10 April 2025 purchase own shares for a maximum amount of DKK 40.0 million.

The share buy-back programme was initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014 about Market Abuse, the so-called Market Abuse Regulation that protects listed companies’ board and executive board against violation of insider legislation in connection with share buy-backs.

See attachment.

Attachment

Meddelelse nr. 06 – Share buy back – 07 02 25 – ENG

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Heimar hf.: Publication of 2024 Annual Report

Xtract One Technologies to be used for Hospital Weapons Detection Screening in Manitoba

Share Buy-back programme at SP Group A/S

Annual Financial Report 2024

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair

Net Asset Value(s)

Topics

Annual Financial Report 2024

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair

Net Asset Value(s)

Danske Mortgage Bank Plc: Annual Report 2024 and Auditor’s report 2024

Plains All American Reports Fourth-Quarter and Full-Year 2024 Results; Provides Update on Efficient Growth Initiatives and Announces 2025 Guidance

Opthea to Present at Oppenheimer Healthcare Conference

Related Articles

Annual Financial Report 2024

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair

Net Asset Value(s)

Company

Headlines

Annual Financial Report 2024

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics

Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair

Newsletter